Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors

Rationale: Prostate cancer (PCa) recurrences after surgery frequently occur. To improve the outcome after surgical resection of the tumor, the theranostic multimodal anti-PSMA targeting agent (111)In-DTPA-D2B-IRDye700DX was developed and characterized for both pre- and intra-operative tumor localiza...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Theranostics
Auteurs principaux: Lütje, Susanne, Heskamp, Sandra, Franssen, Gerben M., Frielink, Cathelijne, Kip, Annemarie, Hekman, Marlène, Fracasso, Giulio, Colombatti, Marco, Herrmann, Ken, Boerman, Otto C., Gotthardt, Martin, Rijpkema, Mark
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2019
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6568177/
https://ncbi.nlm.nih.gov/pubmed/31244933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.35274
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires